stockrowDIH Holding US, Inc.
DHAIDIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.
- Revenue
- −30.7%
- EPS
- +43.1%
- Free cash flow
- −167.9%
Quarter to March 2025, against a year earlier
Follow DHAI
Alert me
DIH Holding US, Inc. (DHAI) Return on invested capital
DIH Holding US, Inc.'s return on invested capital over the twelve months to 31 March 2025 was 0.00%. Over the past ten years it has ranged from −438.6% (fiscal 2022) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −5.22% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 0.00 |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 438.61 |
| FY2022 | −438.6% | (435.36) |
| FY2021 | −3.25% | (3.25) |
| FY2021 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| GCTK GlucoTrack, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| DHAI DIH Holding US, Inc. | 0.00% |
| ICCM IceCure Medical Ltd. compare | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc compare | −27.9% |
| ADGM Adagio Medical Holdings, Inc. compare | −74.6% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| NXL Nexalin Technology, Inc. compare | −1,108.8% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)